期刊文献+
共找到22篇文章
< 1 2 >
每页显示 20 50 100
C-C motif chemokine ligand 2/C-C motif chemokine receptor 2 pathway as a therapeutic target and regulatory mechanism for spinal cord injury
1
作者 Xiangzi Wang Xiaofei Niu +4 位作者 Yingkai Wang Yang Liu Cheng Yang Xuyi Chen Zhongquan Qi 《Neural Regeneration Research》 SCIE CAS 2025年第8期2231-2244,共14页
Spinal cord injury involves non-reversible damage to the central nervous system that is characterized by limited regenerative capacity and secondary inflammatory damage.The expression of the C-C motif chemokine ligand... Spinal cord injury involves non-reversible damage to the central nervous system that is characterized by limited regenerative capacity and secondary inflammatory damage.The expression of the C-C motif chemokine ligand 2/C-C motif chemokine receptor 2 axis exhibits significant differences before and after injury.Recent studies have revealed that the C-C motif chemokine ligand 2/C-C motif chemokine receptor 2 axis is closely associated with secondary inflammatory responses and the recruitment of immune cells following spinal cord injury,suggesting that this axis is a novel target and regulatory control point for treatment.This review comprehensively examines the therapeutic strategies targeting the C-C motif chemokine ligand 2/C-C motif chemokine receptor 2 axis,along with the regenerative and repair mechanisms linking the axis to spinal cord injury.Additionally,we summarize the upstream and downstream inflammatory signaling pathways associated with spinal cord injury and the C-C motif chemokine ligand 2/C-C motif chemokine receptor 2 axis.This review primarily elaborates on therapeutic strategies that target the C-C motif chemokine ligand 2/C-C motif chemokine receptor 2 axis and the latest progress of research on antagonistic drugs,along with the approaches used to exploit new therapeutic targets within the C-C motif chemokine ligand 2/C-C motif chemokine receptor 2 axis and the development of targeted drugs.Nevertheless,there are presently no clinical studies relating to spinal cord injury that are focusing on the C-C motif chemokine ligand 2/C-C motif chemokine receptor 2 axis.This review aims to provide new ideas and therapeutic strategies for the future treatment of spinal cord injury. 展开更多
关键词 apoptosis c-c motif chemokine ligand 2/c-c motif chemokine receptor 2 pathway c-c motif chemokine receptor 2 antagonists chemokine ligand 2 chemokine receptor 2 inflammation macrophage microglia spinal cord injury therapeutic method
下载PDF
C–C motif chemokine ligand 16 inhibits the progression of liver cirrhosis via inactivating hepatic stellate cells 被引量:5
2
作者 Jian-Yong Zhuo Di Lu +5 位作者 Zu-Yuan Lin Bei-Ni Cen Xu-Yong Wei Hai-Yang Xie Shu-Sen Zheng Xiao Xu 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS CSCD 2020年第5期440-448,共9页
Background:Liver cirrhosis results from many forms of chronic damage,characterized by accumulation of extracellular matrix.The present study aimed to explore a potential non-invasive biomarker and its mechanism in the... Background:Liver cirrhosis results from many forms of chronic damage,characterized by accumulation of extracellular matrix.The present study aimed to explore a potential non-invasive biomarker and its mechanism in the progression of liver cirrhosis.Methods:Gene Expression Omnibus(GEO)dataset(GSE15654,n=216)was analyzed to screen genes associated with progression of liver cirrhosis.A total of 181 plasma samples,including healthy control(HC,n=20),chronic hepatitis B(CHB,n=77)and HBV-related liver cirrhosis(LC,n=84),were enrolled for validation.In vitro and in vivo experiments were employed for the mechanistic investigation.Results:GEO dataset analysis showed that relatively low mRNA-expression of C–C motif chemokine ligand 16(CCL16)was associated with elevated Child-Pugh score(P=0.034)and worse prognosis(P=0.025).Plasma CCL16 level decreased in a stepwise pattern,with a median concentration of 10.29,6.57 and 4.47 ng/mL in the HC,CHB and LC groups,respectively(P<0.001).Low plasma CCL16 was significantly related to hepatic dysfunction both in the CHB and LC groups(P<0.05).Combination of CCL16 and ALT showed improved distinguishing capability for LC compared to either alone.In vitro,CCL16 expression was downregulated by lipopolysaccharide and hypoxia.Overexpression of CCL16 from human normal liver cell line(LO2)reduced the extracellular matrix associated proteins(Col1 and Col4)in human hepatic stellate cell line(LX-2).In vivo,the pathological feature of cirrhosis was alleviated by the hepatocytespecific expression of CCL16.Conclusions:CCL16 could be a feasible plasma marker to predict the occurrence and progression of liver cirrhosis.CCL16 might impact liver cirrhosis through inactivating hepatic stellate cells. 展开更多
关键词 c-c motif chemokine ligand 16 Liver cirrhosis Hepatitis B virus infection
下载PDF
Macrophage migration inhibitory factor facilitates astrocytic production of the CCL2 chemokine following spinal cord injury 被引量:1
3
作者 Han Zhang Yu-Ming Hu +6 位作者 Ying-Jie Wang Yue Zhou Zhen-Jie Zhu Min-Hao Chen Yong-Jun Wang Hua Xu You-Hua Wang 《Neural Regeneration Research》 SCIE CAS CSCD 2023年第8期1802-1808,共7页
Spinal cord injury causes accumulation of a large number of leukocytes at the lesion site where they contribute to excessive inflammation.Overproduced chemokines are responsible for the migratory process of the leukoc... Spinal cord injury causes accumulation of a large number of leukocytes at the lesion site where they contribute to excessive inflammation.Overproduced chemokines are responsible for the migratory process of the leukocytes,but the regulatory mechanism underlying the production of chemokines from resident cells of the spinal cord has not been fully elucidated.We examined the protein levels of macrophage migration inhibitory factor and chemokine C-C motif chemokine ligand 2 in a spinal cord contusion model at different time points following spinal cord injury.The elevation of macrophage migration inhibitory factor at the lesion site coincided with the increase of chemokine C-C motif chemokine ligand 2 abundance in astrocytes.Stimulation of primary cultured astrocytes with different concentrations of macrophage migration inhibitory factor recombinant protein induced chemokine C-C motif chemokine ligand 2 production from the cells,and the macrophage migration inhibitory factor inhibitor 4-iodo-6-phenylpyrimidine attenuated the stimulatory effect.Further investigation into the underlying mechanism on macrophage migration inhibitory factor-mediated astrocytic production of chemokine C-C motif chemokine ligand 2 revealed that macrophage migration inhibitory factor activated intracellular JNK signaling through binding with CD74 receptor.Administration of the macrophage migration inhibitory factor inhibitor 4-iodo-6-phenylpyrimidine following spinal cord injury resulted in the reduction of chemokine C-C motif chemokine ligand 2-recruited microglia/macrophages at the lesion site and remarkably improved the hindlimb locomotor function of rats.Our results have provided insights into the functions of astrocyte-activated chemokines in the recruitment of leukocytes and may be beneficial to develop interventions targeting chemokine C-C motif chemokine ligand 2 for neuroinflammation after spinal cord injury. 展开更多
关键词 ASTROCYTES CD74 chemokine chemokine c-c motif chemokine ligand 2(CCL2) cytokine inflammation LEUKOCYTE MAPKS migration inhibitory factor spinal cord injury
下载PDF
溃疡性结肠炎患者血清CXCL16、CCL20与炎症因子和黏膜愈合的关系
4
作者 蔡涛 张婷 +2 位作者 刘银奎 邓爽 唐闯 《国际检验医学杂志》 CAS 2024年第15期1799-1804,1810,共7页
目的探讨溃疡性结肠炎(UC)患者血清CXC型趋化因子配体16(CXCL16)、趋化因子配体20(CCL20)与炎症因子和黏膜愈合的关系。方法选取2021年1月至2022年10月成都市双流区第一人民医院/四川大学华西空港医院收治的UC患者170例作为研究组,另选... 目的探讨溃疡性结肠炎(UC)患者血清CXC型趋化因子配体16(CXCL16)、趋化因子配体20(CCL20)与炎症因子和黏膜愈合的关系。方法选取2021年1月至2022年10月成都市双流区第一人民医院/四川大学华西空港医院收治的UC患者170例作为研究组,另选取同期在该院体检的健康者100例作为对照组。比较两组血清CXCL16、CCL20与炎症因子[白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)、白细胞介素-17(IL-17)、肿瘤坏死因子-α(TNF-α)、C反应蛋白(CRP)]水平,并分析UC患者血清CXCL16、CCL20与炎症因子的相关性。根据UC患者治疗后黏膜愈合预后情况分为愈合良好组和愈合不良组,比较不同预后患者血清CXCL16、CCL20水平。采用单因素及多因素Logistic回归分析模型分析UC患者治疗后黏膜愈合不良的危险因素,并采用受试者工作特征(ROC)曲线分析血清CXCL16、CCL20对UC患者治疗后黏膜愈合不良的预测价值。结果研究组血清CXCL16、CCL20、IL-1β、IL-6、TNF-α、IL-17及CRP水平显著高于对照组,差异有统计学意义(P<0.05)。Pearson相关分析显示,UC患者血清CXCL16、CCL20分别与IL-1β、IL-6、TNF-α、IL-17及CRP呈正相关(P<0.05),血清CXCL16与CCL20呈正相关(P<0.05)。愈合不良组血清CXCL16、CCL20水平显著高于愈合良好组,差异有统计学意义(P<0.05)。多因素Logistic回归分析显示,CXCL16水平升高、CCL20水平升高、饮酒史、病情分级重度、红细胞沉降率(ESR)水平升高、CRP水平升高是UC患者治疗后黏膜愈合不良的危险因素(P<0.05)。ROC曲线结果显示,血清CXCL16、CCL20联合检测预测UC患者治疗后黏膜愈合不良的曲线下面积(AUC)较大,血清CXCL16、CCL20联合ESR、CRP预测UC患者治疗后黏膜愈合不良的AUC最大。结论UC患者血清CXCL16、CCL20水平与炎症因子密切相关,且联合检测对UC患者治疗后黏膜愈合不良具有较高的预测价值。 展开更多
关键词 溃疡性结肠炎 CXC型趋化因子配体16 趋化因子配体20 炎症因子 预后
下载PDF
血清sST2、CCL20水平对脊柱骨折合并脊髓损伤患者预后的预测价值
5
作者 常运光 李来华 +2 位作者 栗向军 马娅敏 王立志 《医学理论与实践》 2024年第10期1635-1638,共4页
目的:探索血清可溶性致癌抑制因子2(sST2)、趋化因子配体20(CCL20)水平对脊柱骨折合并脊髓损伤患者预后的预测价值。方法:选取2020年1月—2022年5月在本院采用椎管减压手术治疗的117例脊柱骨折合并脊髓损伤患者作为疾病组,同期选择采用... 目的:探索血清可溶性致癌抑制因子2(sST2)、趋化因子配体20(CCL20)水平对脊柱骨折合并脊髓损伤患者预后的预测价值。方法:选取2020年1月—2022年5月在本院采用椎管减压手术治疗的117例脊柱骨折合并脊髓损伤患者作为疾病组,同期选择采用椎管减压手术治疗的112例单纯脊柱骨折患者作为对照组。检测两组患者血清sST2、CCL20的表达水平,对疾病组患者进行1年的随访,根据预后情况将疾病组患者分为预后良好组(69例)及预后不良组(48例),收集患者的临床资料进行分析;采用多因素Logistic回归分析脊柱骨折合并脊髓损伤患者预后不良的影响因素;受试者工作特征(ROC)曲线分析血清sST2、CCL20检测对脊柱骨折合并脊髓损伤患者预后不良的预测价值。结果:疾病组患者血清sST2、CCL20的表达水平高于对照组患者(P<0.05);预后不良患者血清sST2、CCL20表达水平高于预后良好患者(P<0.05);血清sST2、CCL20是脊柱骨折合并脊髓损伤患者预后不良的影响因素(P<0.05);sST2、CCL20联合预测脊柱骨折合并脊髓损伤患者预后不良的曲线下面积(AUC)显著大于sST2、CCL20单独诊断的AUC(P<0.05),其敏感度为95.83%,特异度为86.96%。结论:脊柱骨折合并脊髓损伤患者血清sST2、CCL20表达水平升高,是患者预后不良的影响因素,sST2、CCL20联合检测能够预测脊柱骨折合并脊髓损伤预后不良的风险。 展开更多
关键词 可溶性致癌抑制因子2 趋化因子配体20 脊柱骨折合并脊髓损伤 预后
下载PDF
Intestinal epithelial chemokine (C-C motif) ligand 7 overexpression protects against high fat diet-induced obesity and hepatic steatosis in mice 被引量:1
6
作者 Zhi-Hong Luo Meng-Wei Niu +7 位作者 Shen-Hai Gong Guang-Yan Wu Teng Wang Fang-Zhao Wang Guo-Quan Wei Zhan-Ke He Yong Jiang Peng Chen 《Chinese Medical Journal》 SCIE CAS CSCD 2020年第15期1805-1814,共10页
Background:We previously found that the intestinal epithelial chemokine(C-C motif)ligand 7(CCL7)plays an important role in the development of toxin-induced acute liver damage.The detailed effects of intestinal epithel... Background:We previously found that the intestinal epithelial chemokine(C-C motif)ligand 7(CCL7)plays an important role in the development of toxin-induced acute liver damage.The detailed effects of intestinal epithelial CCL7 on chronic diseases;however,are still unclear.Here,we aimed to investigate the impact of intestinal epithelial CCL7 overexpression on high-fat diet(HFD)-induced obesity and steatohepatitis in mice.Methods:Intestinal epithelial CCL7 overexpression(CCL7tgIEC)mice and their wild-type(WT)littermates were fed with normal chow or HFD for 16 weeks to induce obesity and non-alcoholic fatty liver disease.Body weight gain,as well as adipose tissue index were assessed.Liver injury was monitored by histological analysis and real time polymerase chain reaction.Gut microbial composition was analyzed by 16S rRNA gene sequencing.Results:We found that the CCL7tgIEC mice on a HFD had markedly decreased weight gain(8.9 vs.17.0 g,P<0.05)and a lower adipose tissue index that include mesenteric fat(1.0%vs.1.76%,P<0.05),gonadal fat(2.1%vs.6.1%,P<0.05),subcutaneous fat(1.0%vs.2.8%,P<0.05)compared to WT animals.HFD-induced glucose intolerance and insulin resistance were also significantly improved in CCL7tgIEC mice compared to WT.Furthermore,HFD-fed CCL7tgIEC mice displayed less hepatic lipid accumulation and lower expression of inflammatory factors than WT mice.16S rRNA gene sequencing demonstrated that CCL7 overexpression in intestinal epithelial cells improved HFD-induced gut microbial dysbiosis.Conclusions:Our study revealed that CCL7 overexpression in the intestinal epithelium protects mice against the progression of diet-induced obesity,hepatic steatosis,and enteric dysbiosis. 展开更多
关键词 chemokine(c-c motif)ligand 7 Gut microbiota High-fat diet Obesity STEATOHEPATITIS
原文传递
窄谱中波紫外线对人永生化角质形成细胞C-C基序趋化因子配体20表达的影响
7
作者 郑小乐 王萍 +2 位作者 阳知丽 吴妙婷 陆捷洁 《中国热带医学》 CAS 北大核心 2024年第9期1112-1115,共4页
目的探讨银屑病治疗方法窄谱中波紫外线(narrowband ultraviolet B,NB-UVB)照射对人永生化角质形成细胞(HaCaT cells)中C-C基序趋化因子配体20(CCL20)的mRNA和蛋白表达的影响与潜在作用机制。方法将常规培养后的HaCaT细胞分为2组,第一组... 目的探讨银屑病治疗方法窄谱中波紫外线(narrowband ultraviolet B,NB-UVB)照射对人永生化角质形成细胞(HaCaT cells)中C-C基序趋化因子配体20(CCL20)的mRNA和蛋白表达的影响与潜在作用机制。方法将常规培养后的HaCaT细胞分为2组,第一组HaCaT细胞采用不同剂量的NB-UVB照射,照射剂量分别为0、100、200、400 mJ/cm^(2),并分别培养3、12、24 h后进行处理;第二组HaCaT细胞分别经1.0、12.5、25.0μmol/L浓度吡咯烷二硫代甲酸铵(pyrrolidine dithiocarbamate,PDTC)预处理后,采用400 mJ/cm^(2)NB-UVB进行照射。逆转录聚合酶链反应(reverse transcription-polymerase chain reaction,RT-PCR)检测细胞培养裂解液中CCL20 mRNA的表达;蛋白免疫印迹法(West‑ern blot)检测HaCaT细胞中的CCL20,核因子κB(nuclear factor kappa-B,NF-κB)p65和磷酸化NF-κB p65蛋白的表达;酶联免疫吸附分析(enzyme-linked immunosorbent assay,ELISA)法检测HaCaT细胞培养上清液中CCL20蛋白表达。结果NB-UVB照射后,HaCaT细胞中CCL20 mRNA表达水平和细胞培养上清液中CCL20蛋白表达水平随着NB-UVB照射剂量的增加而增加,差异具有统计学意义(P<0.05)。NB-UVB照射后,HaCaT细胞中NF-κB p65的磷酸化水平随着照射剂量增加而增加(P<0.05)。与单纯NB-UVB处理组相比,PDTC预处理的HaCaT细胞中,CCL20 mRNA和蛋白表达水平以及NF-κB p65的磷酸化水平,均有不同程度降低(P<0.05),且均呈现剂量依赖性,随着PDTC剂量增加,降低程度更为明显。结论NB-UVB能够通过活化NF-κB信号通路调节HaCaT细胞趋化因子CCL20的表达和分泌。 展开更多
关键词 银屑病 窄谱中波紫外线 人永生化角质形成细胞 c-c基序趋化因子配体20 核因子ΚB
原文传递
外周血CCL20与Th17细胞比例对病毒感染致心肌炎病情进展的影响 被引量:4
8
作者 王宁 袁文清 胡会 《医学检验与临床》 2020年第4期10-13,54,共5页
目的:探讨外周血CCL20与Th17细胞比例与病毒感染致心肌炎(VMC)患者病情进展的关联关系。方法:选取2016年5月~2019年5月间,我院心血管内科收治的病毒性心肌炎患者96例作为研究对象,按病程分为急性期41例,慢性期20例,恢复期35例,另取健康... 目的:探讨外周血CCL20与Th17细胞比例与病毒感染致心肌炎(VMC)患者病情进展的关联关系。方法:选取2016年5月~2019年5月间,我院心血管内科收治的病毒性心肌炎患者96例作为研究对象,按病程分为急性期41例,慢性期20例,恢复期35例,另取健康受试者40例作为对照组。采用酶联免疫吸附(ELISA)试剂盒检测外周血CCL20和白介素-17(IL-17)水平,采用流式细胞仪检测外周血Th17细胞、CD4+细胞、CCR6^+细胞、Treg细胞,分析不同疾病阶段外周血CCL20、IL-17水平变化以及Th17细胞与CD4^+、CCR6^+、Treg比例的关系。结果:急性期组和慢性期组病毒性心肌炎患者的外周血CCL20和IL-17水平及Th17/CD4^+、CCR6^+/Th17等指标,均明显高于恢复期组和对照组,且慢性期组水平明显高于急性期组(P<0.05)。而Treg/CD4^+水平情况相反,急性期组和慢性期组均明显低于恢复期组和对照组,且慢性期组水平明显低于急性期组(P<0.05);相关性分析结果提示VMC患者外周血CCL20、IL-17与Th17/CD4^+呈正相关关系(r分别为0.463,0.412,P<0.05),而Treg/CD4^+与Th17/CD4^+呈负相关关系(r=-0.326,P<0.05)。结论:病毒性心肌炎患者急性期和慢性期外周血CCL20、IL-17水平升高,Th17细胞比例失衡,可能是疾病病程进展的重要机制。 展开更多
关键词 病毒性心肌炎 细胞因子 CCL20 TH17细胞 流式细胞
下载PDF
基于癌基因组图谱数据挖掘分析CC亚族趋化因子配体20在食管癌中的表达及临床意义 被引量:1
9
作者 秦波 王正洋 +2 位作者 殷凡响 闫丹 朱珠 《解剖学报》 CAS CSCD 北大核心 2022年第1期60-65,共6页
目的探讨CC亚族趋化因子配体20(CCL20)在食管癌中的表达及对病程进展和预后的影响。方法利用癌基因组图谱(TCGA)、UALCAN、GEO等相关数据库分析CCL20基因在食管癌组织与癌旁组织中的表达差异,通过Kaplan-Meier模型探讨CCL20表达水平与... 目的探讨CC亚族趋化因子配体20(CCL20)在食管癌中的表达及对病程进展和预后的影响。方法利用癌基因组图谱(TCGA)、UALCAN、GEO等相关数据库分析CCL20基因在食管癌组织与癌旁组织中的表达差异,通过Kaplan-Meier模型探讨CCL20表达水平与预后的关联性;分析CCL20与肥胖、甲基化等之间的关系;最后通过mRNA、蛋白水平,分析CCL20在食管癌组织和癌旁组织的表达差异。结果CCL20在食管癌尤其是腺癌类型中高表达,高表达CCL20患者生存率明显降低;CCL20的表达量与食管癌患者肥胖程度成正比、与其甲基化程度成反比;食管癌组织中CCL20的表达量显著增加。结论CCL20在食管癌组织中高表达,且CCL20高表达与患者的生存预后成显著负相关。 展开更多
关键词 食管癌 CC亚族趋化因子配体20 癌基因组图谱数据库 预后 免疫组织化学
原文传递
Neuroinflammation in mild respiratory COVID‑19:insights into cognitive impairment in milder cases
10
作者 Qian Li Chun Dang Li‑Hua Wang 《Military Medical Research》 SCIE CAS CSCD 2023年第4期556-558,共3页
Severe acute respiratory syndrome coronavirus 2(SARSCoV-2)infection has been extensively shown to cause many neurological sequelae,and cognitive deficits(known as“brain fog”)may particularly and widely occur even in... Severe acute respiratory syndrome coronavirus 2(SARSCoV-2)infection has been extensively shown to cause many neurological sequelae,and cognitive deficits(known as“brain fog”)may particularly and widely occur even in individuals with mild symptoms[1].Peripheral hyperinflammation as well as central nervous system(CNS)local immune responses may synergistically contribute to brain autoimmune injury.In addition to the direct neuroinvasion of SARS-CoV-2 and nonimmune effects such as severe systemic hypoxemia and vascular thrombosis,the central mechanism by which SARSCoV-2 accelerates cognitive-related symptoms may be related to immune effects[2].However,the precise neuroinflammatory mechanisms of SARS-CoV-2 infection have not been fully established.Fernández-Casta-da et al.[3]provided direct evidence and unique insights into the potential mechanism of cognitive impairment in mild respiratory coronavirus disease 2019(COVID-19)cases. 展开更多
关键词 Coronavirus disease 2019(COVID-19) Cognitive impairment NEUROINFLAMMATION MICROGLIA c-c motif chemokine ligand 11(CCL11)
原文传递
自身免疫性肝炎患者血清趋化因子和GP73水平变化及其临床意义研究 被引量:6
11
作者 凌晶 张友健 宋雄峰 《实用肝脏病杂志》 CAS 2020年第6期825-828,共4页
目的探讨自身免疫性肝炎(AIH)患者血清趋化因子和高尔基体糖蛋白73(GP73)水平的变化及其临床意义。方法2018年3月~2019年3月我院就诊的46例自身免疫性肝炎患者和46例同期健康人群,采用ELIS法检测血清趋化因子C-C-基元受体6和20(CCR6、CC... 目的探讨自身免疫性肝炎(AIH)患者血清趋化因子和高尔基体糖蛋白73(GP73)水平的变化及其临床意义。方法2018年3月~2019年3月我院就诊的46例自身免疫性肝炎患者和46例同期健康人群,采用ELIS法检测血清趋化因子C-C-基元受体6和20(CCR6、CCL20)、血清趋化因子配体10(CXCL10)和GP73水平。AIH患者接受肝活检,并将肝炎程度分为轻中重度。结果AIH血清CCR6、CCL20、CXCL10和GP73水平分别为(112.4±59.3)pg/mL、(186.5±71.8)pg/mL、(81.5±42.0)pg/mL和(171.4±62.5)ng/mL,均显著高于健康人[分别为(75.8±32.6)pg/mL、(123.7±42.2)pg/mL、(53.9±28.1)pg/mL和(83.1±35.2)ng/mL,P<0.05];10例重度患者血清CCR6、CCL20、CXCL10和GP73水平分别为(174.2±81.4)pg/mL、(271.5±99.7)pg/mL、(162.7±83.1)pg/mL和(278.3±91.5)ng/mL,,显著高于14例中度组[分别为(124.5±55.3)pg/mL、(198.6±66.9)pg/mL、(88.4±46.8)pg/mL和(186.2±75.8)ng/mL,P<0.05]或22例轻度组[分别为(83.5±34.5)pg/mL、(155.6±51.0)pg/mL、(42.6±22.7)pg/mL和(123.9±58.9)ng/mL,P<0.05];26例肝组织G3~4级患者血清CCR6、CCL20、CXCL10和GP73水平分别为(154.5±28.1)pg/mL、(201.6±56.3)pg/mL、(98.4±56.1)pg/mL和(196.2±59.78)ng/mL,显著高于20例G1~2级组[分别为(73.5±34.8)pg/mL、(135.6±41.7)pg/mL、(62.5±20.1)p g/mL和(93.9±33.9)ng/mL,P<0.05]。结论AIH患者血清CCR6、CCL20、CXCL10和GP73水平升高,且随着疾病程度和肝组织炎症活动度加重而升高。检测自身免疫性肝炎患者血清趋化因子和GP73水平可能有助于评估患者病情的变化。 展开更多
关键词 自身免疫性肝炎 趋化因子c-c-基元受体6 趋化因子c-c-基元配体20 趋化因子配体10 高尔基体糖蛋白73
下载PDF
Transforming growth factor-β and toll-like receptor-4 polymorphisms are not associated with fibrosis in haemochromatosis 被引量:1
12
作者 Marnie J Wood Lawrie W Powell +2 位作者 Jeannette L Dixon V Nathan Subramaniam Grant A Ramm 《World Journal of Gastroenterology》 SCIE CAS 2013年第48期9366-9376,共11页
AIM:To investigate the role of genetic polymorphisms in the progression of hepatic fibrosis in hereditary haemochromatosis.METHODS:A cohort of 245 well-characterised C282Y homozygous patients with haemochromatosis was... AIM:To investigate the role of genetic polymorphisms in the progression of hepatic fibrosis in hereditary haemochromatosis.METHODS:A cohort of 245 well-characterised C282Y homozygous patients with haemochromatosis was studied,with all subjects having liver biopsy data and DNA available for testing.This study assessed the association of eight single nucleotide polymorphisms(SNPs)in a total of six genes including toll-like receptor 4(TLR4),transforming growth factor-beta(TGF-β),oxoguanine DNA glycosylase,monocyte chemoattractant protein 1,chemokine C-C motif receptor 2 and interleukin-10 with liver disease severity.Genotyping was performed using high resolution melt analysis and sequencing.The results were analysed in relation to the stage of hepatic fibrosis in multivariate analysis incorporating other cofactors including alcohol consumption and hepatic iron concentration.RESULTS:There were significant associations between the cofactors of male gender(P=0.0001),increasing age(P=0.006),alcohol consumption(P=0.0001),steatosis(P=0.03),hepatic iron concentration(P<0.0001)and the presence of hepatic fibrosis.Of the candidate gene polymorphisms studied,none showed a significant association with hepatic fibrosis in univariate or multivariate analysis incorporating cofactors.We also specifically studied patients with hepatic iron loading above threshold levels for cirrhosis and compared the genetic polymorphisms between those with no fibrosis vs cirrhosis however there was no significant effect from any of the candidate genes studied.Importantly,in this large,well characterised cohort of patients there was no association between SNPs for TGF-βor TLR4and the presence of fibrosis,cirrhosis or increasing fibrosis stage in multivariate analysis.CONCLUSION:In our large,well characterised group of haemochromatosis subjects we did not demonstrate any relationship between candidate gene polymorphisms and hepatic fibrosis or cirrhosis. 展开更多
关键词 HAEMOCHROMATOSIS Genetic polymorphism Liver FIBROSIS TOLL-LIKE receptor 4 Interleukin 10 Monocyte CHEMOATTRACTANT protein 1 chemokine(c-c motif) ligand 2 Transforming growth factor beta 8-oxoguanine DNA GLYCOSYLASE
下载PDF
G蛋白偶联受体75去孤儿化研究及在疾病中的作用 被引量:1
13
作者 吉雨恬 刘恋恋 +5 位作者 刘娇莉 张淳 李开远 郭立荣 曾俊伟 韩勇 《中国病理生理杂志》 CAS CSCD 北大核心 2022年第12期2278-2284,共7页
G蛋白偶联受体(G-protein-coupled receptors,GPCRs)是已知人类基因组中最大的一类膜蛋白受体家族,包括A类视紫红质样受体、B类分泌素受体、C类代谢型谷氨酸受体、D类真菌交配信息素受体、E类环腺苷酸受体及F类卷曲受体(Frizzled/Smooth... G蛋白偶联受体(G-protein-coupled receptors,GPCRs)是已知人类基因组中最大的一类膜蛋白受体家族,包括A类视紫红质样受体、B类分泌素受体、C类代谢型谷氨酸受体、D类真菌交配信息素受体、E类环腺苷酸受体及F类卷曲受体(Frizzled/Smoothened家族)[1-2]。其中A类视紫红质样受体包含了GPCRs中大部分种类,共含有19个子类(A1~A19)719种. 展开更多
关键词 G蛋白偶联受体75 去孤儿化 20-羟二十烷四烯酸 c-c基序趋化因子配体5
下载PDF
急性病毒性心肌炎患者CCL20对Th17细胞趋化性作用 被引量:2
14
作者 余淼 张景辉 +2 位作者 杨仕俊 廖玉华 袁璟 《临床心血管病杂志》 CAS CSCD 北大核心 2011年第2期89-91,共3页
目的:探讨CCL20与急性病毒性心肌炎(AVMC)患者Th17细胞趋化性的关系。方法:选择11例AVMC患者为研究对象,同时选取10例健康人作为对照。利用siRNA技术干预AVMC患者外周血巨噬细胞,将其分为A(不接受siRNA转染)、B(接受CCL20 siRNA转染)、C... 目的:探讨CCL20与急性病毒性心肌炎(AVMC)患者Th17细胞趋化性的关系。方法:选择11例AVMC患者为研究对象,同时选取10例健康人作为对照。利用siRNA技术干预AVMC患者外周血巨噬细胞,将其分为A(不接受siRNA转染)、B(接受CCL20 siRNA转染)、C(阴性对照,接受scramble siRNA转染)亚组。应用ELISA法检测AVMC组患者血清CCL20及其巨噬细胞体外分泌CCL20的水平,趋化实验和流式细胞学结合观察体外不同水平CCL20对Th17细胞的趋化能力及表达CCL20受体CCR6的Th17细胞比例的影响,实时定量PCR法检测趋化板下室细胞表面CCR6mRNA的表达。结果:与健康对照组[(2.78±0.64)μg/L]相比,AVMC组患者体内血清CCL20水平[(11.36±2.45)μg/L]明显升高,P<0.05。体外实验中,B亚组巨噬细胞培养上清CCL20含量、趋化实验募集的Th17细胞比例、表达CCR6的Th17细胞比例和CCR6mRNA相对表达水平[(0.94±0.08)ng/L、(6.86±0.59)%、(2.56±0.78)%、(0.36±0.08)]均低于A亚组[(2.57±0.25)ng/L、(9.74±0.77)%、(4.55±0.84)%、(1.00±0.15)]和C亚组[(2.08±0.17)ng/L、(9.16±0.82)%、(4.12±0.43)%、(0.88±0.17)],均P<0.05,而A、C亚组间各参数差异均无统计学意义。结论:AVMC患者中Th17细胞趋化性与巨噬细胞分泌的CCL20有关。 展开更多
关键词 心肌炎 辅助性T细胞17 CCL20
原文传递
溃疡性结肠炎患者外周血中CC趋化因子配体20表达水平及意义 被引量:2
15
作者 张健 董荣坤 +6 位作者 陈亮 汪启斌 黄建朋 张征 王佩 甘云辉 汪彪 《中华实验外科杂志》 CAS CSCD 北大核心 2015年第6期1424-1425,共2页
目的 检测溃疡性结肠炎(UC)患者外周血中CC趋化因子配体20(CCL20)表达水平,分析CCL20表达水平与UC严重程度的关系.方法 入组52例UC患者(根据病情分为轻、中、重度)及30例健康体检者(对照组),分别收集外周血,Trizol法提取外周血... 目的 检测溃疡性结肠炎(UC)患者外周血中CC趋化因子配体20(CCL20)表达水平,分析CCL20表达水平与UC严重程度的关系.方法 入组52例UC患者(根据病情分为轻、中、重度)及30例健康体检者(对照组),分别收集外周血,Trizol法提取外周血中淋巴细胞总RNA,用实时定量聚合酶链反应(Real-time PCR)检测CCL20 mRNA表达水平;酶联免疫吸附试验(ELISA)检测外周血中CCL20蛋白质表达水平,独立样本t检验比较两组外周血中CCL20表达水平,方差分析比较轻、中、重度UC患者CCL20表达水平的差异.结果 UC组患者外周血中CCL20蛋白表达为(2 040.03 ± 730.07) ng/L,对照组外周血中CCL20蛋白表达为(550.01 ±70.71) ng/L,两组差异有统计学意义(P<0.05);轻、中、重度UC患者外周血中CCL20蛋白表达水平分别为(1 233.33±251.66)、(2300.01 ±300.00)、(3 034.56±152.75) ng/L,其差异有统计学意义(P<0.05).结论 UC患者外周血中CCL20表达增高,CCL20可能参与UC的发病. 展开更多
关键词 CC趋化因子配体20 外周血 溃疡性结肠炎
原文传递
Transferrin receptor-targeted immunostimulant for photodynamic immunotherapy against metastatic tumors through β-catenin/CREB interruption
16
作者 Mengyi Yan Xiayun Chen +9 位作者 Xiaotong Li Qianqian Liu Baixue Yu Yi Cen Wei Zhang Yibin Liu Xinxuan Li Ying Chen Tao Wang Shiying Li 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2024年第9期4118-4133,共16页
The immunosuppressive phenotype of tumor cells extensively attenuates the immune activation effects of traditional treatments.In this work,a transferrin receptor(TfR)targeted immunostimulant(PTI)is fabricated for phot... The immunosuppressive phenotype of tumor cells extensively attenuates the immune activation effects of traditional treatments.In this work,a transferrin receptor(TfR)targeted immunostimulant(PTI)is fabricated for photodynamic immunotherapy against metastatic tumors by interrupting β-catenin signal pathway.To synthesize PTI,the photosensitizer conjugated TfR targeting peptide moiety(Palmitic-K(PpIX)-HAIYPRH)is unitized to encapsulate the transcription interrupter of ICG-001.On the one hand,the recognition of PTI and TfR can promote drug delivery into tumor cells to destruct primary tumors through photodynamic therapy and initiate an immunogenic cell death with the release of tumorassociated antigens.On the other hand,PTI will interrupt the binding between b-catenin andcAMP response element-binding protein(CREB),regulating the gene transcription to downregulate programmed death ligand 1(PD-L1)while upregulating CeC motif chemokine ligand 4(CCL4).Furthermore,the elevated CCL4 can recruit the dendritic cells to present tumor-specific antigens and promote T cells activation and infiltration,and the downregulated PD-L1 can avoid the immune evasion of tumor cells and activate systemic anti-tumor immunity to eradicate lung metastasis.This work may inspire the development of antibody antibody-free strategy to activate systemic immune response in consideration of immunosuppressive conditions. 展开更多
关键词 Transferrin receptor β-Catenin signal pathway Tumor targeting Photodynamic therapy IMMUNOTHERAPY Immunogenic cell death Programmed death ligand 1 c-c motif chemokine ligand 4
原文传递
CCL16 inhibits tumor proliferation and metastasis in HCC by impacting CK19 phenotype
17
作者 Huigang Li Jianyong Zhuo +13 位作者 Peiru Zhang Jinyan Chen Zuyuan Lin Xudong Yang Ruijie Zhao Chenghao Cao Wei Shen Chiyu He Hao Chen Ting Lv Xuyong Wei Shusen Zheng Xiao Xu Di Lu 《iLIVER》 2024年第2期43-52,共10页
Background and aims:Cytokeratin 19-positive(CK19t)hepatocellular carcinoma(HCC)is an aggressive subtype with poor outcomes.The initiation and development of CK19t HCC in the background of liver cirrhosis remains uncle... Background and aims:Cytokeratin 19-positive(CK19t)hepatocellular carcinoma(HCC)is an aggressive subtype with poor outcomes.The initiation and development of CK19t HCC in the background of liver cirrhosis remains unclear.This study investigated the role of the cirrhosis-related gene C-C motif chemokine ligand 16(CCL16)in the development of CK19t HCC.Methods:Datasets from Gene Expression Omnibus(GEO),The Cancer Genome Atlas(TCGA)and International Cancer Genome Consortium(ICGC)were analyzed to screen and validate the genes associated with CK19t HCC.A total of 102 HCC patients were included for tissue microarray analysis.Gain-of-function experiments were conducted to investigate the biological functions of CCL16.CIBERSORT was used to investigate the correlation of CCL16 and immune infiltration.Results:GEO dataset analysis showed that CK19t HCC had lower expression of CCL16.In both TCGA dataset and our HCC cohort,CCL16 expression was negatively correlated with CK19 expression(P<0.05)and its expression was higher in para-tumor than tumor tissues(P<0.001).Moreover,low CCL16 expression was related to advanced stage and poor overall survival(P<0.05).CCL16 overexpression downregulated CK19 expression and impacted the sphere formation ability of HCC cells.Overexpression of CCL16 inhibited the cell proliferation,migration,and invasion of HCC cell lines.Immune analysis showed HCC with high CCL16 expression had more infiltration of mast cells.HCC patients with both low CCL16 expression and low mast cells had the worst prognosis(P<0.001).Conclusion:Our data indicated that CCL16 downregulated the expression of CK19 and inhibited the malignant phenotype of HCC. 展开更多
关键词 Hepatocellular carcinoma Cytokeratin 19 c-c motif chemokine ligand 16 Mast cells Prognosis
原文传递
清除CCL20对小鼠银屑病免疫微环境调控的影响研究 被引量:1
18
作者 彭诗亚 杨娟 +2 位作者 吴倩 诸蓉 王儒鹏 《重庆医学》 CAS 2022年第11期1818-1823,共6页
目的探讨清除CC趋化因子配体20(CCL20)后小鼠银屑病样皮炎发病过程中免疫微环境的改变。方法将12只雌性C57BL/6小鼠背部皮肤脱毛后分为实验组和对照组,各6只。使用咪喹莫特(IMQ)构建小鼠银屑病皮肤炎症模型,其中实验组小鼠注射CCL20抗体... 目的探讨清除CC趋化因子配体20(CCL20)后小鼠银屑病样皮炎发病过程中免疫微环境的改变。方法将12只雌性C57BL/6小鼠背部皮肤脱毛后分为实验组和对照组,各6只。使用咪喹莫特(IMQ)构建小鼠银屑病皮肤炎症模型,其中实验组小鼠注射CCL20抗体,对照组小鼠注射同等体积磷酸盐缓冲液(PBS),观察两组小鼠银屑病样皮损面积与严重程度指数(PASI)评分变化,并于造模第7天处死小鼠取材,通过苏木素-伊红(HE)染色、免疫组织化学染色及流式细胞学检测分析造模区域免疫微环境发生的变化。结果相较于对照组,实验组小鼠红斑及鳞屑PASI评分明显降低。HE染色结果显示,相较于对照组,实验组小鼠表皮厚度明显减小,皮下炎性细胞(以淋巴细胞为主)浸润明显减少,新生毛细血管减少(P<0.05)。流式细胞学检测结果显示,相较于对照组,实验组小鼠表皮γδT淋巴细胞(主要为Vγ4^(+)T淋巴细胞)百分比、白细胞介素(IL)-17A^(+)T淋巴细胞百分比明显降低(P<0.05)。免疫组织化学结果显示,相较于对照组,实验组小鼠造模区皮肤炎症因子IL-17A、γ干扰素(IFN-γ)、CXCL8及IL-23表达水平均明显降低(P<0.05)。结论清除小鼠体内CCL20可改善银屑病样皮炎免疫微环境,减轻银屑病样皮炎对皮肤造成的破坏。 展开更多
关键词 银屑病 咪喹莫特 免疫微环境 CC趋化因子配体20 小鼠
下载PDF
Expression Changes of Serum IL-1α,CCL2,and CXCL2 in Patients With Pemphigus
19
作者 Li-Dan Mao Yu Zhang +3 位作者 Jun-Qin Liang Xiao-Jing Kang Feng-Xia Hu Fan-He Jiang 《International Journal of Dermatology and Venereology》 CSCD 2023年第2期102-106,共5页
Objective:This study was performed to explore the possible changes of the serum levels of the cytokines including interleukin 1α(IL-1α),chemokine monocyte chemotactic protein 1(also known as chemokine[C-C motif]liga... Objective:This study was performed to explore the possible changes of the serum levels of the cytokines including interleukin 1α(IL-1α),chemokine monocyte chemotactic protein 1(also known as chemokine[C-C motif]ligand 2[CCL2]),and C-X-C motif chemokine ligand 2(CXCL2)in patients with pemphigus.Methods:The expression levels of IL-1α,CCL2,and CXCL2 in the serum of 57 patients with pemphigus PV(including 42 patients in progressive stage and 15 patients in remission stage)and 31 healthy controls were examined by enzyme-linked immunosorbent assay.The indepent-samples t-test was used to compare the two groups.Oneway analysis of variance was used for multiple-group comparisons,and the post-hoc least significant difference test was used to detect differences among multiple groups.Results:The serum expression levels of CCL2 and IL-1a were all significantly higher in the patients in progressive stage than in the controls([2.69±0.23]ng/mL vs.[2.55±0.28]ng/mL,P=0.043;[0.62±0.27]ng/mL vs.[0.48±0.23]ng/mL,P=0.038,respectively).In addition,the serum expression level of CXCL2 was significantly higher in patients in progressive stage than in in the remission stage([61.70±46.38]ng/mL vs.[24.97±18.46]ng/mL,P=0.037).Sex,disease classification,disease severity,treatment,and mucosal involvement had no significant influence on the expression of IL-1α,CCL2,or CXCL2 in the serum of patients groups and controls(all P>0.05).Conclusion:IL-1α,CCL2,and CXCL2 are heavily involved in the occurrence and development of pemphigus and may be related to the activity of the disease. 展开更多
关键词 PEMPHIGUS cytokines chemokine INTERLEUKIN-1Α chemokine(c-c motif)ligand 2 C-X-C motif chemokine ligand 2
原文传递
Spinal CCL2 Promotes Central Sensitization, Long-Term Potentiation, and Inflammatory Pain via CCR2: Further Insights into Molecular, Synaptic, and Cellular Mechanisms 被引量:20
20
作者 Rou-Gang Xie Yong-Jing Gao +5 位作者 Chul-Kyu Park Ning Lu Ceng Luo Wen-Ting Wang Sheng-Xi Wu Ru-Rong Ji 《Neuroscience Bulletin》 SCIE CAS CSCD 2018年第1期13-21,共9页
Mounting evidence supports an important role of chemokines, produced by spinal cord astrocytes, in promoting central sensitization and chronic pain. In particular, CCL2 (C-C motif chemokine ligand 2) has been shown ... Mounting evidence supports an important role of chemokines, produced by spinal cord astrocytes, in promoting central sensitization and chronic pain. In particular, CCL2 (C-C motif chemokine ligand 2) has been shown to enhance N-methyl-D-aspartate (NMDA)-induced currents in spinal outer lamina II (Iio) neurons. However, the exact molecular, synaptic, and cellular mechanisms by which CCL2 modulates central sensitization are still unclear. We found that spinal injection of the CCR2 antagonist RS504393 attenuated CCL2- and inflammation-induced hyperalgesia. Single-cell RT-PCR revealed CCR2 expres- sion in excitatory vesicular glutamate transporter subtype 2-positive (VGLUT2+) neurons. CCL2 increased NMDA- induced currents in CCR2+/VGLUT2+ neurons in lamina IIo; it also enhanced the synaptic NMDA currents evoked by dorsal root stimulation; and furthermore, it increased the total and synaptic NMDA currents in somatostatin- expressing excitatory neurons. Finally, intrathecal RS504393 reversed the long-term potentiation evoked in the spinal cord by C-fiber stimulation. Our findings suggest that CCL2 directly modulates synaptic plasticity in CCR2- expressing excitatory neurons in spinal lamina Iio, and this underlies the generation of central sensitization in patho- logical pain. 展开更多
关键词 chemokineS c-c motif chemokine ligand 2 (CCL2) Monocyte chemoattractant protein 1 (MCP-1) Neuron-glial interaction
原文传递
上一页 1 2 下一页 到第
使用帮助 返回顶部